20.01.2022 23:35:00

Why Novavax Stock Tumbled on Thursday

Coronavirus stock Novavax (NASDAQ: NVAX) was a bit sickly on Thursday. The biotech's shares declined by just over 2% on the day, a steeper fall than that suffered by the S&P 500 index. While the company had some good news to report, it wasn't enough to move the stock price upward.The latest development comes from over the Pacific Ocean, specifically Australia. After market hours on Wednesday, Novavax announced that the nation's Therapeutic Goods Administration (TGA) has approved the provisional registration of NVX-CoV2373. That's the company's coronavirus vaccine, which holds either authorization or approval in a number of jurisdictions around the world.Image source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Onmehr Analysen

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!

Aktien in diesem Artikel

Novavax Inc. 47,49 -3,80% Novavax Inc.
On 20,40 0,89% On